Posted: November 6, 2020

Applications due 30 days prior to application; Applications due March 17, 2021

The purpose of this Funding Opportunity Announcement (FOA) is to support research on the development and validation of innovative strategies to deliver anti-HIV gene therapies efficiently to specific target cells in vivo.

See full solicitation here

Office of Grants and Contracts


107 Ag Administration Building
University Park, PA 16802